Xilio Therapeutics, Inc.
XLO
$0.71
-$0.03-4.44%
NASDAQ
| 09/30/2025 | 06/30/2025 | 03/31/2025 | 12/31/2024 | 09/30/2024 | |
|---|---|---|---|---|---|
| Total Cash And Short-Term Investments | 103.76M | 121.55M | 89.07M | 55.29M | 61.26M |
| Total Receivables | 17.50M | -- | 2.00M | 2.00M | -- |
| Inventory | -- | -- | -- | -- | -- |
| Prepaid Expenses | 2.83M | 2.17M | 2.13M | 2.94M | 2.05M |
| Finance Division Loans and Leases Current | -- | -- | -- | -- | -- |
| Total Finance Division Other Current Assets | -- | -- | -- | -- | -- |
| Other Current Assets | -- | -- | -- | -- | -- |
| Total Current Assets | 124.09M | 123.72M | 93.20M | 60.23M | 63.31M |
|
|
|||||
| Total Current Assets | 124.09M | 123.72M | 93.20M | 60.23M | 63.31M |
| Net Property, Plant & Equipment | 7.80M | 8.30M | 8.73M | 9.06M | 9.57M |
| Long-term Investments | -- | -- | -- | -- | -- |
| Goodwill | -- | -- | -- | -- | -- |
| Total Other Intangibles | -- | -- | -- | -- | -- |
| Finance Div Loans & Leases LT | -- | -- | -- | -- | -- |
| Total Finance Div Other LT Assets | -- | -- | -- | -- | -- |
| Total Other Assets | 1.80M | 1.79M | 1.79M | 1.78M | 1.78M |
| Total Assets | 133.69M | 133.81M | 103.72M | 71.08M | 74.66M |
|
|
|||||
| Total Accounts Payable | 2.30M | 4.10M | 2.28M | 2.57M | 972.00K |
| Total Accrued Expenses | 8.95M | 5.62M | 3.88M | 9.98M | 9.79M |
| Short-term Debt | -- | -- | -- | -- | -- |
| Current Portion of Long-Term Debt/Capital Leases | -- | -- | -- | -- | -- |
| Finance Division Debt Current | 1.30M | 1.26M | 1.23M | 1.19M | 1.15M |
| Total Finance Division Other Current Liabilities | 43.85M | 42.28M | 40.25M | 13.52M | 26.11M |
| Total Other Current Liabilities | 43.85M | 42.28M | 40.25M | 13.52M | 26.11M |
| Total Current Liabilities | 56.40M | 53.26M | 47.64M | 27.26M | 38.02M |
|
|
|||||
| Total Current Liabilities | 56.40M | 53.26M | 47.64M | 27.26M | 38.02M |
| Long-Term Debt | -- | -- | -- | -- | -- |
| Short-term Debt | -- | -- | -- | -- | -- |
| Capital Leases | 5.96M | 6.30M | 6.64M | 6.95M | 7.26M |
| Finance Division Debt Non Current | -- | -- | -- | -- | -- |
| Total Finance Division Other Non Current Liabilities | -- | -- | -- | -- | -- |
| Total Other Liabilities | 79.43M | 67.18M | 38.74M | 19.26M | 8.40M |
| Total Liabilities | 141.79M | 126.74M | 93.02M | 53.48M | 53.68M |
|
|
|||||
| Common Stock & APIC | 421.05M | 419.93M | 407.72M | 401.35M | 391.63M |
| Retained Earnings | -429.15M | -412.86M | -397.02M | -383.75M | -370.66M |
| Treasury Stock & Other | -- | -- | -- | -- | -- |
| Total Common Equity | -8.10M | 7.07M | 10.70M | 17.60M | 20.97M |
|
|
|||||
| Preferred Stock Redeemable | -- | -- | -- | -- | -- |
| Preferred Stock Non Redeemable | -- | -- | -- | -- | -- |
| Preferred Stock Convertible | -- | -- | -- | -- | -- |
| Preferred Stock, Others | -- | -- | -- | -- | -- |
| Total Preferred Equity | -- | -- | -- | -- | -- |
|
|
|||||
| Total Common Equity | -8.10M | 7.07M | 10.70M | 17.60M | 20.97M |
| Total Preferred Equity | -- | -- | -- | -- | -- |
| Total Minority Interest | -- | -- | -- | -- | -- |
| Total Equity | -8.10M | 7.07M | 10.70M | 17.60M | 20.97M |
|
|
|||||